End-of-treatment and serial PET imaging in primary mediastinal B-cell lymphoma following dose-adjusted EPOCH-R: a paradigm shift in clinical decision making

Dose-adjusted-EPOCH-R obviates the need for radiotherapy in most patients with primary mediastinal B-cell lymphoma. End-of-treatment PET, however, does not accurately identify patients at risk of treatment failure, thereby confounding clinical decision making. To define the role of PET in primary me...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Haematologica
Autores principales: Melani, Christopher, Advani, Ranjana, Roschewski, Mark, Walters, Kelsey M., Chen, Clara C., Baratto, Lucia, Ahlman, Mark A., Miljkovic, Milos D., Steinberg, Seth M., Lam, Jessica, Shovlin, Margaret, Dunleavy, Kieron, Pittaluga, Stefania, Jaffe, Elaine S., Wilson, Wyndham H.
Formato: Artigo
Lenguaje:Inglês
Publicado: Ferrata Storti Foundation 2018
Materias:
Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC6068044/
https://ncbi.nlm.nih.gov/pubmed/29748435
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3324/haematol.2018.192492
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares